Photo by Timothy A. Clary / AFP via Getty Images
With the promise of a COVID-19 vaccine in the distant future and positive signs from a recent Moderna MRNA, +1.98% trial, public-health professionals are mulling which groups of people should get early doses. And some are weighing a controversial idea: moving people of color, whose communities have been disproportionately stricken by the disease, toward the front of the queue.
For the full story, visit MarketWatch.com/News.
